Company news
Zhejiang Starry Pharmaceutical Co., Ltd. news in 2026
Zhejiang Starry Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2026, newest first.
(603520)"Zhejiang Starry Pharmaceutical Co., Ltd."Report for Q3 2026
October 27, 2026
(603520)"Zhejiang Starry Pharmaceutical Co., Ltd."Announcement on Resolutions of the 4th Meeting of the 6th Board of Directors
October 27, 2026
(603520)"Zhejiang Starry Pharmaceutical Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance and Cash Dividend Briefing
October 14, 2026
Announcement on Implementation of Dividend Distribution for the First Half of 2026
September 6, 2026
Announcement on Resolutions of the 2nd Meeting of the 6th Board of Directors
August 30, 2026
Announcement on Results of Shareholding Reduction by the Actual Controller and Completion of Internal Share Transfer Among Persons Acting in Concert
August 13, 2026
Announcement on Release of Pledge over Shares Held by the Controlling Shareholder
July 16, 2026
Change in Equity of Shareholders with Over 5% Shares Reaching 1% Threshold
July 13, 2026
Announcement on Pledge of Partial Shares of Controlling Shareholder
July 7, 2026
Announcement on Release of the Pledge over Shares Held by the Controlling Shareholder
July 3, 2026
Announcement on Resolutions of the 1st Meeting of the 6th Board of Directors
June 15, 2026
Announcement on Convening Performance and Cash Dividend Meeting for 2025 and Q1 2026
June 8, 2026
Announcement on Implementation of Dividend Distribution for 2025
May 28, 2026
Announcement on Election of Employee Representative Directors for the 6th Board of Directors
May 22, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 20, 2026
Announcement on Obtaining Government Subsidies
May 11, 2026
Announcement on the Actual Controller Adding a Concerted Party and a Plan for Internal Transfer of Shares among Persons Acting in Concert and Shareholding Reduction Plan
May 7, 2026
Indicative Announcement on Election of Board of Directors at Expiry of Term of Office
April 29, 2026
Announcement on Progress in Selling Equity of Joint-stock Company
April 9, 2026
Announcement on Outward Investment and Related Party Transactions
April 8, 2026
Announcement on Acquisition of Equity in Ruishi Pharmaceutical
March 23, 2026
Announcement on Release of Pledge and New Pledge of Controlling Shareholder's Shares
February 6, 2026
Announcement on Expected Increase in Performance for 2025
January 30, 2026
Announcement on Subsidiary Completing Industrial and Commercial Change Registration and Obtaining Business License
January 16, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
January 13, 2026
Announcement on Cancellation of Special Accounts for Raised Funds
December 31, 2025